Skip to main content

Table 5 Incremental effects of GA, FBG, and HbA1c on risk stratification for the MACCE beyond existing risk factors

From: Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

  Chi-square value Harrell’s C-index Continuous-NRI IDI
Estimation 95% CI P for comparison Estimation 95% CI P value Estimation 95% CI P value
Baseline model 235.533 0.684 0.663–0.706
 + GA 260.704 0.694 0.673–0.715 0.002 0.085 − 0.004–0.138 0.053 0.007 0.001–0.017 0.020
 + FBG 257.774 0.692 0.671–0.713 0.001 0.087 − 0.002–0.144 0.053 0.005 0.000–0.013 0.040
 + HbA1c 258.198 0.693 0.672–0.714 0.005 0.048 − 0.012–0.103 0.106 0.006 0.001–0.014 0.033
  1. The baseline model included age, gender, BMI, smoking history, family history of CAD, hypertension, T2DM, anemia, NSTEMI, creatinine, TC, LVEF, LM lesion, multi-vessel lesion and SYNTAX score
  2. NRI net reclassification improvement, IDI integrated discrimination improvement, CI confidence interval
  3. GA glycated albumin, FBG fasting blood glucose, HbA1c glycosylated hemoglobin A1c